Our Concern is Patient Health & Safety

STIO Pharmacovigilance Group Contact Details

STIO QPPV
Mail: [email protected]
Tel.: 0224500837

Please enable JavaScript in your browser to complete this form.

Patient Initials *

First

Last

Date of birth *

Age *

Layout diminish

Gender *

Male
Female

Country

Date of adverse reaction (copy) *

Check all appropriate to adverse reaction

Involved or prolonged inpatient hospitalization
Involved persistence / significance / disability
Life threatening
Congenital anomaly
Other

Paragraph Text

Suspect drug(s) information *

Did reaction diminish after stopping drug?

Yes
No
N/A

Did reaction reappear after re-administration? *

Yes
No
N/A

Health-care provider

Pharmacist
Physician
Patient
Other

Single Line Text

Single Line Text (copy)

Numbers

Paragraph Text

Date of this report

Report type *

Initial
Follow up

Your Email *

Subject *

STIO is an Egyptian family-owned Private Joint Stock company established in 2016 with an authorized capital of EGP 500 million and a paid-in capital of EGP 100 million

Our Links

About us
Our Board
Products
News
Pipeline
Career
Contact Us

Contact Info

33 Nazih Khalifa, Heliopolis , Cairo, Egypt

0224500837

Our Location

Home Call Us Products Contact

Our Concern is Patient Health & Safety

STIO Pharmacovigilance Group Contact Details

STIO QPPVMail: [email protected]Tel.: 0224500837

STIO QPPV
Mail: [email protected]
Tel.: 0224500837